Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07212712Not yet recruiting
Single-arm trial of estradiol and testosterone, sponsored by University of British Columbia. Primary endpoints: Cerebral blood flow responses to estrogen and testosterone at 7 days and Cerebral metabolic changes with estrogen and testosterone at 4 days. Planned start Apr 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07212712.